Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Am J Surg. 2023 Oct 5;227:132–136. doi: 10.1016/j.amjsurg.2023.10.009

Table 2.

Data stratified by Black versus White race.

All Patients White (N = 219) Black (N = 70) p-value

Patient Characteristics
Age at diagnosis (years) 65 (52–73) 58 (51–66) 0.01
Female 104 (47.5 %) 49 (70.0 %) 0.01
BMI, median 28.1 (24.6–32.3) 29.3 (25.8–35.2) 0.06
Prior history of unrelated cancer 46 (21.0 %) 6 (8.6 %) 0.02
Tumor Characteristics
Tumor size (cm) 8.5 (4.5–14.5) 9.5 (6.3–15.4) 0.20
Mitoses 84 (38.3) 25 (35.7) 0.93
Necrosis 78 (35.6 %) 34 (48.6 %) 0.13
Hemorrhage 42 (19.2 %) 17 (24.3 %) 0.14
Stage at Diagnosis 0.82
Non-metastatic 181 (82.6 %) 57 (81.4 %)
Metastatic 38 (17.4 %) 13 (18.6 %)
Treatment, n (%)
Neoadjuvant chemotherapy 14 (6.4 %) 8 (11.4 %) 0.38
Surgery 191 (87.2 %) 57 (81.4 %) 0.42
Radiation 91 (41.6 %) 27 (38.6 %) 0.66
Outcomes
Follow-up time (days) 474 (247–1075) 322 (134–704) 0.01
Death 77 (35.2 %) 30 (42.9 %) 0.25